Companies: 10,795·Total market cap: $144.5T
Coya Therapeutics, Inc.

Coya Therapeutics, Inc.

COYANASDAQHealthcare● Active
$4.54
+$0.12(+2.71%)
Market Cap$82667734
P/E Ratio
52W High$7.75
52W Low$3.71
Overview

Coya Therapeutics, Inc. (COYA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · COYA · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.15coya eps ttm · coya earnings per shareEarnings history
PE Ratio (TTM)coya pe ratio ttm · coya price to earningsPE Ratio deep dive
Revenue (TTM)$7.9Mcoya revenue ttm · coya annual revenueFull revenue history
Dividend YieldNo Dividenddoes coya pay dividends · coya dividend yieldDividend history
Shares Outstanding16.7Mcoya shares outstanding · coya floatShares outstanding history
Next EarningsAug 11, 2026Est.coya earnings date · coya next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$7.9M▲ +123.57% YoY
202320242025
coya therapeutics, inc. revenue · coya revenue 2025
FY 2025Net Income-$21.2M▼ 42.64% YoY
202320242025
coya therapeutics, inc. net income · coya profit 2025
FY 2025EPS$-1.27▼ 29.59% YoY
202320242025
coya eps · coya therapeutics, inc. earnings per share 2025
TTM:Revenue: $7.9MNet Income: -$21.1MEPS: $-1.15View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis coya a buy · coya analyst rating
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$12.00Low
$4.54Current
$12.00Avg Target164.32% upside
$12.00High
coya price target · coya 12 month forecast

Total: 5 · Buy rate: 100.0%

The COYA analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +164.32% upside from the current price of $4.54.

Stock Performance

Full History
1D+2.94%
1W-3.60%
1M+10.71%
3M-5.01%
YTD-21.55%
1Y-22.62%
5Y-0.44%

About Coya Therapeutics, Inc.

CEOArun Swaminathan
IPO DateDec 29, 2022
Employees8
CountryUS

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipelin…

what is coya therapeutics, inc. · coya stock overview · coya therapeutics, inc. company profile · who is coya therapeutics, inc. ceo · coya NASDAQ · coya therapeutics, inc. headquarters · coya therapeutics, inc. business segments

About Stock Overview & Key Data

Coya Therapeutics, Inc. (COYA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 29, 2022. As of the latest trading session, COYA stock price is $4.54, with a market capitalization of $82.8M. The stock has returned -22.62% over the past 12 months and -21.55% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Coya Therapeutics, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Coya Therapeutics, Inc. reported revenue of $7.9M and net income of -$21.2M. For detailed data — including Coya Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Coya Therapeutics, Inc. (COYA) stock price is $4.54. The stock is traded on NASDAQ under the ticker symbol COYA. The 52-week range is $3.71 – $7.75.

COYA stock priceCOYA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice